The Cost and Burden of Chronic Pain

Phillips, Ceri

doi:10.1177/204946370900300102

Cited by 269 publications

(209 citation statements)

References 32 publications

Supporting

Mentioning

203

Contrasting

Unclassified

Order By: Relevance

“…1,2 These two conditions frequently occur simultaneously, and the association appears to be bi-directional; this adds to the complexity of managing either condition independently. Studies to assess the effectiveness of weight-loss interventions on individuals with co-existing chronic musculoskeletal pain have shown that weight reduction can be achieved and is associated with lower pain scores; 3,4 however, no systematic review has been conducted to determine the most effective intervention or participants’ perceptions of the appropriateness and sustainability of interventions to inform clinical practice.…”

Section: Introductionmentioning

confidence: 99%

“…14 Approximately, five million adults in the UK annually develop chronic pain that impacts on their ability to work, thereby having an effect on business and the economy. 2 Although the total cost of chronic pain is unknown, the cost to the exchequer annually is in excess of £12.3 billion for back pain alone and 2.7 million people with chronic musculoskeletal pain are in receipt of incapacity benefit. 14,15 Although back pain and osteoarthritis (OA) (particularly of the knee) account for 50% of chronic pain, other conditions such as rheumatoid arthritis (RA), migraine, chronic daily headache and neck pain are also common.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Weight-loss interventions for overweight/obese adults with chronic musculoskeletal pain

Cooper¹,

Ryan²,

Ells³

et al. 2016

JBI Database of Systematic Reviews and Implementation Reports

View full text Add to dashboard Cite

Review question/objective The objective of this mixed methods review is to develop an aggregated synthesis of qualitative and quantitative data on weight-loss interventions for overweight/obese adults with chronic musculoskeletal pain in an attempt to derive conclusions and recommendations useful for clinical practice and policy decision making. The objective of the quantitative component of this review is to quantify the effectiveness of weight-loss interventions on weight, pain and physical and/or psychosocial function in overweight/obese adults with chronic musculoskeletal pain. The objectives of the qualitative component of this review are to explore the perceptions and experiences of overweight/obese adults with chronic musculoskeletal pain of the link between their weight and pain, and the effectiveness and appropriateness of weight-loss interventions and sustainability of weight-loss efforts.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Weight-loss interventions for overweight/obese adults with chronic musculoskeletal pain

Cooper¹,

Ryan²,

Ells³

et al. 2016

JBI Database of Systematic Reviews and Implementation Reports

View full text Add to dashboard Cite

show abstract

“…In the United States, the cost of chronic pain is as high as $635 billion a year — more than the annual costs for cancer, diabetes, and heart disease [26]; and the economic burden of pain is similarly greater than most other health conditions around the world [55]. …”

Section: Introductionmentioning

confidence: 99%

Supporting the Self-Management of Chronic Pain Conditions with Tailored Momentary Self-Assessments

Adams

Murnane

Elfenbein

et al. 2017

Proceedings of the 2017 CHI Conference on Human Factors in Computing Systems

View full text Add to dashboard Cite

To better support the self-management of chronic pain, this paper investigates how those living with the condition prefer to self-assess their pain levels using smartphones. Our work consists of three stages: design ideation and review, an in-lab user study with 10 participants resulting in nine candidate interfaces, and a 3 week field trial of two further honed measures with 12 participants. This research firstly yields a better understanding of participants’ strong and sometimes contrasting preferences regarding their self-assessment of pain intensity. We additionally contribute two novel interfaces that support accurate, quick, and repeated use along with other participant-valued interactions (e.g., familiar, relatable, and highly usable). In particular, we focus on designing tailored measures that both enhance respondent motivation as well as minimize the difficulty of meaningful self-assessment by supporting the cog-nitive effort in translating a subjective experience into a single numerical value.

show abstract

“…Chronic pain, defined as pain which has persisted for greater than 3 months, is a widespread and complex condition [1]. Over 40% of all chronic musculoskeletal pain conditions are associated with chronic back pain (CBP) [2,3] and CBP has been documented to present a significant financial and emotional burden both to the individual and society [2,[4][5][6]. Treatments that are ineffective and poorly tolerated can drive up direct healthcare costs [7].…”

mentioning

confidence: 99%

An Over-the-Counter Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief, Medication Use and Their Adverse Effects

2016

View full text Add to dashboard Cite

aim: Back pain, the most prevalent musculoskeletal chronic pain condition, is usually treated with analgesic medications of questionable efficacy and frequent occurrence of adverse side effects. objective: The objective was to determine the effectiveness of the ActiPatch medical devices in reducing chronic back pain, document medication related adverse side effects and establish their impact on quality of life. methods: Upon completing a 7-day trial, subjects were contacted via email with an assessment form using the Constant Contact email program. A total of 1394 responses were collected from subjects who used the device for back pain. Conclusion: Medication adverse effects are common and impact quality of life in the lay population. ActiPatch is an effective intervention for the majority of subjects for treating chronic back pain, although this requires further investigation in randomized clinical trials. • Subjects in this study had chronic back pain (CBP), with a mean pain duration averaging 6.1 years.• Pain etiologies demonstrated a heterogeneous subject population of CBP sufferers.• About 96% of the subjects were using analgesics medications averaging 2.5 per subject, with 71% using prescription analgesics.• The majority of individuals using analgesic medications for CBP report less than adequate pain relief.• Adverse effects from pain medications are common (66%) for CBP sufferers.• CBP sufferers, who report chronic pain for longer than 2 years, also detail using approximately 25% more prescription analgesics than those who have experienced the pain for less than 2 years.• The number of adverse effects is directly proportional to the number of prescription analgesics being used.• The increase in the number of adverse side effects negatively impacts quality of life.• The majority of CBP users, upon using the ActiPatch®, reported a clinically significant reduction in pain within 7 days.• Nearly 50% of the study subjects were able to eliminate or decrease analgesic medications after 7 days of use of the medical device.• The ActiPatch was effective in reducing CBP for the majority of subjects as well as reducing their analgesic use.For reprint orders, please contact: reprints@futuremedicine.com

show abstract

The Cost and Burden of Chronic Pain

Cited by 269 publications

References 32 publications

Weight-loss interventions for overweight/obese adults with chronic musculoskeletal pain

Weight-loss interventions for overweight/obese adults with chronic musculoskeletal pain

Supporting the Self-Management of Chronic Pain Conditions with Tailored Momentary Self-Assessments

An Over-the-Counter Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief, Medication Use and Their Adverse Effects

Contact Info

Product

Resources

About